In membranous nephropathy, which immunosuppressive approach is described as prednisone plus another agent?

Study for the NBME Form 13 Test with our comprehensive quiz collection, featuring flashcards and multiple-choice questions to ensure your readiness. Enhance your knowledge with detailed explanations for each question.

Multiple Choice

In membranous nephropathy, which immunosuppressive approach is described as prednisone plus another agent?

Explanation:
In membranous nephropathy, the treatment goal is to suppress the autoimmune process that drives the disease. The classic immunosuppressive approach described as prednisone plus another agent is prednisone combined with cyclophosphamide. Cyclophosphamide is an alkylating agent that dampens B-cell activity and antibody production, while prednisone provides broad immunosuppression and anti-inflammatory effects. Together, they reduce the formation of pathogenic immune complexes along the glomerular basement membrane and help decrease proteinuria. Other options like prednisone alone, azathioprine alone, or prednisone with methotrexate aren’t the standard combination described for this condition.

In membranous nephropathy, the treatment goal is to suppress the autoimmune process that drives the disease. The classic immunosuppressive approach described as prednisone plus another agent is prednisone combined with cyclophosphamide. Cyclophosphamide is an alkylating agent that dampens B-cell activity and antibody production, while prednisone provides broad immunosuppression and anti-inflammatory effects. Together, they reduce the formation of pathogenic immune complexes along the glomerular basement membrane and help decrease proteinuria. Other options like prednisone alone, azathioprine alone, or prednisone with methotrexate aren’t the standard combination described for this condition.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy